Bausch Health Companies Inc. Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
Bausch Health Companies Inc. (BHC) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $57.00 million for the 12-month period ending 2015-12-31, per its 8-K filed 2018-08-10.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2018-08-10
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-12-31 was $35.30M.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-09-30 was -$3.90M, a 124.53% decline year-over-year.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-06-30 was $7.70M.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2015-03-31 was $17.90M, a 1391.67% increase year-over-year.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2014 was $17.00M, a 29.75% decline from fiscal 2013.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2013 was $24.20M, a 93.60% increase from fiscal 2012.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2012 was $12.50M, a 52.68% decline from fiscal 2011.
- Bausch Health Companies Inc. adjustments to additional paid in capital, income tax benefit from share-based compensation for fiscal 2011 was $26.41M.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 9 month as first filed | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $35.30M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $31.40M derived: sum of 2 quarters · filed 2018-08-10 | $39.10M derived: sum of 3 quarters · filed 2018-08-10 | $57.00M 8-K · filed 2018-08-10 | $56.80M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | -$3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-26 | $3.80M derived: sum of 2 quarters · filed 2015-10-26 | $21.70M 10-Q · filed 2015-10-26 | $21.60M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $7.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $25.60M 10-Q · filed 2015-07-28 | $25.50M derived: sum of 3 quarters · filed 2017-03-01 | $41.40M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $17.90M 10-Q · filed 2015-04-30 | $17.80M derived: sum of 2 quarters · filed 2017-03-01 | $33.70M derived: sum of 3 quarters · filed 2017-03-01 | $33.70M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $15.80M derived: sum of 2 quarters · filed 2017-03-01 | $15.80M derived: sum of 3 quarters · filed 2017-03-01 | $17.00M 10-K · filed 2017-03-01 | $17.10M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $15.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-26 | $15.90M derived: sum of 2 quarters · filed 2015-10-26 | $17.10M 10-Q · filed 2015-10-26 | -$7.30M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | $1.20M 10-Q · filed 2015-07-28 | -$23.20M derived: sum of 3 quarters · filed 2016-04-29 | $9.00M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $1.20M 10-Q · filed 2015-04-30 | -$23.20M derived: sum of 2 quarters · filed 2016-04-29 | $9.00M derived: sum of 3 quarters · filed 2016-04-29 | $20.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | -$24.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $7.80M derived: sum of 2 quarters · filed 2016-04-29 | $19.60M derived: sum of 3 quarters · filed 2016-04-29 | $24.20M 10-K · filed 2016-04-29 | ||||
| 2013-09-30 | $32.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-24 | $44.00M derived: sum of 2 quarters · filed 2014-10-24 | $48.60M 10-Q · filed 2014-10-24 | $48.63M 10-Q · filed 2013-11-01 | $55.26M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $16.40M 10-Q · filed 2014-08-01 | $16.45M 10-Q · filed 2013-08-07 | $23.06M derived: sum of 3 quarters · filed 2015-02-25 | $25.43M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-03-31 | $4.60M 10-Q · filed 2014-05-09 | $4.60M 10-Q · filed 2013-05-03 | $11.26M derived: sum of 2 quarters · filed 2015-02-25 | $13.63M derived: sum of 3 quarters · filed 2015-02-25 | $16.51M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $9.03M derived: sum of 2 quarters · filed 2015-02-25 | $11.91M derived: sum of 3 quarters · filed 2015-02-25 | $12.50M 10-K · filed 2015-02-25 | $12.54M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $5.25M derived: sum of 2 quarters · filed 2013-11-01 | $5.84M 10-Q · filed 2013-11-01 | -$513.00K derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $3.48M 10-Q · filed 2013-08-07 | -$2.88M derived: sum of 3 quarters · filed 2014-02-28 | -$814.00K derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $593.00K 10-Q · filed 2013-05-03 | -$5.76M derived: sum of 2 quarters · filed 2014-02-28 | -$3.70M derived: sum of 3 quarters · filed 2014-02-28 | $3.83M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$6.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$4.29M derived: sum of 2 quarters · filed 2014-02-28 | $3.24M derived: sum of 3 quarters · filed 2014-02-28 | $26.41M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $9.60M derived: sum of 2 quarters · filed 2012-11-05 | $32.77M 10-Q · filed 2012-11-05 | |||||
| 2011-06-30 | $7.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $30.70M 10-Q · filed 2012-08-03 | ||||||
| 2011-03-31 | $23.17M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |